Alzheimer's drug that can slow disease gets backing from FDA

WASHINGTON — A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with

Related Keywords

Japan , Washington , United States , Japanese , Thomas Montine , Tanya Simuni , Eli Lilly , Drug Administration , Stanford University , National Institutes Of Health , Northwestern University , Dean Follmann , National Institutes ,